databyte

Article

A report from telecom consulting firm Analysys warns that ASPs are promising too much to customers too soon, and that high-profile failures will damage the industry. Even so, Analysys believes the ASP market will balloon to $82 billion by 2005.

A report from telecom consulting firm Analysys warns that ASPs are promising too much to customers too soon, and that high-profile failures will damage the industry. Even so, Analysys believes the ASP market will balloon to $82 billion by 2005. Opportunities abound for data center services, connectivity, security, site design, billing, and even the applications themselves, according to Margaret Hopkins, principal analyst and author of the Analysys report. The challenge for ASPs is to keep costs down and achieve economies of scale quickly, while managing customer expectations of services such as broadband access, Hopkins said. The report finds that the most stable model is enterprise ASPs targeting top level corporations. Service level agreements are also critical in addressing customer concerns about security and reliability levels.


© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 7.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.